prazosin has been researched along with Adult Spinal Muscular Atrophy in 1 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boyd, PJ | 1 |
Tu, WY | 1 |
Shorrock, HK | 1 |
Groen, EJN | 1 |
Carter, RN | 1 |
Powis, RA | 1 |
Thomson, SR | 1 |
Thomson, D | 1 |
Graham, LC | 1 |
Motyl, AAL | 1 |
Wishart, TM | 1 |
Highley, JR | 1 |
Morton, NM | 1 |
Becker, T | 1 |
Becker, CG | 1 |
Heath, PR | 1 |
Gillingwater, TH | 1 |
1 other study available for prazosin and Adult Spinal Muscular Atrophy
Article | Year |
---|---|
Bioenergetic status modulates motor neuron vulnerability and pathogenesis in a zebrafish model of spinal muscular atrophy.
Topics: Adenosine Triphosphate; Animals; Axons; Disease Models, Animal; Disease Susceptibility; Energy Metab | 2017 |